Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
BackgroundThe gut microbiome may play a role in the pathogenesis of neuropsychiatric diseases including major depressive disorder (MDD). Bile acids (BAs) are steroid acids that are synthesized in the liver from cholesterol and further processed by gut-bacterial enzymes, thus requiring both human and...
Main Authors: | Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, Christopher R. Brydges, Wei Jia, Oliver Fiehn, A. John Rush, Boadie W. Dunlop, Rima Kaddurah-Daouk |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.937906/full |
Similar Items
-
Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment
by: Sudeepa Bhattacharyya, et al.
Published: (2019-09-01) -
Metabolic profiling of patients with schizophrenia.
by: Rima Kaddurah-Daouk
Published: (2006-08-01) -
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
by: Marlon P. Quinones, et al.
Published: (2009-08-01) -
Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
by: Christopher R. Brydges, et al.
Published: (2021-10-01) -
Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder
by: Caroline W. Grant, et al.
Published: (2022-03-01)